IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Veeda Clinical Research IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ [●] Cr. The company is based in Ahmedabad and caters to Pharmaceutical sector. Axis Bank , Clsa India , Iifl Securities , SBI Capital Markets are the merchant bankers of Veeda Clinical Research IPO. It is a MainBoard Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 31st January 2025.
Veeda Clinical Research IPO open date is [●] and close date is [●]. IPO Allotment Date is [●] and Listing date is [●].
IPO
Size:
₹ Cr.
Avg IPO Size (Sector Based)
: ₹
1,342.04 cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Axis Bank
IPO by BRLM so far:
26
City:
Ahmedabad
IPO so far:
14
Revenue (annualised):
₹
631.60
cr. 
PE
Ratio:
x
Average Sector PE Ratio: 25.12x
Veeda Clinical Research IPO size is ₹ [●] with IPO price of ₹ [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Axis Bank Limited is the book-running lead manager of the Veeda Clinical Research IPO. MUFG Intime India Private Limited is the Registrar for Veeda Clinical Research IPO.
Veeda Clinical Research IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Veeda Clinical Research IPO, based in Ahmedabad, operates in the Pharmaceutical sector with a focus on . The company is launching its MainBoard Upcoming IPO on the BSE,NSE exchange, using the Book Building Issue method. Veeda Clinical Research IPO size is ₹ [●] with fresh issue size of ₹ [●] and Offer for sale being ₹ Nil
The IPO allotment date for Veeda Clinical Research IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Veeda Clinical Research IPO allotment status on the registrars website, MUFG Intime India Private Limited. Veeda Clinical Research IPO refund dates are [●].
Veeda Clinical Research IPO is expected to be listed on [●].
The upper price band for the Veeda Clinical Research IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Veeda Clinical Research IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Veeda Clinical Research IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Veeda Clinical Research IPO is finalised.
The merchant banker for Veeda Clinical Research IPO is Axis Bank Limited , Clsa India Private Limited , Iifl Securities Limited , SBI Capital Markets Limited . Axis Bank Limited , Clsa India Private Limited , Iifl Securities Limited , SBI Capital Markets Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Veeda Clinical Research IPO RHP for further details.
The registrar for Veeda Clinical Research IPO is MUFG Intime India Private Limited. Investors can go to MUFG Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Veeda Clinical Research IPO through their official website or helpline.
Veeda Clinical Research IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
[●]
Avg IPO Size (Sector Based)
:
₹ 1,342.04 Cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Axis Bank
IPO by BRLM so far:
26
City:
Ahmedabad
IPO so far:
14
Revenue (annualised):
₹ 610.58 cr.
PE
Ratio:
[●]
Average Sector PE Ratio: 25.12x
Veeda Clinical Research IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Veeda Clinical Research Financial Review Page
Merchant Banker(s) of Veeda Clinical Research IPO: Axis Bank Limited , Clsa India Private Limited , Iifl Securities Limited , SBI Capital Markets Limited
Veeda Clinical Research IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Veeda Clinical Research IPO listed at a listing price of against the offer price of .
The current market price of Veeda Clinical Research is .
Why Us?
